AI-generated summary
In a study of 72 male rats with 5 mm skull defects, the authors compared blood clot alone, Bio-Oss bone matrix, 660 nm photobiomodulation, and the combination. They report that the photobiomodulation and blood clot groups had the highest proportion of bone neoformation at 60 days, while the combined group had more than twice the neoformation of the Bio-Oss group at 30 days.
- Participants
- 72
- Who or what was studied
- 72 adult male Wistar rats, 90 days old, with 5 mm calvarial critical size defects
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract reports a single-session, animal-only design with immunohistochemistry described only as semi-quantitative, and it does not state whether the differences were statistically significant.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 45 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.